ANGELA MCCOY: Open Payments
NPI 1073018487 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$150 in 8 payments from 5 companies in 2025. Trend: 2023 $112 · 2024 $543 · 2025 $150
Food & beverage: $150
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $41 |
| AstraZeneca Pharmaceuticals LP | 2 | $38 |
| Lilly USA, LLC | 2 | $37 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| Paratek Pharmaceuticals, Inc. | 1 | $15 |
Products named: Ozempic, AIRSUPRA, MOUNJARO, SHINGRIX, NUZYRA.
Industry payments across OK — which companies pay providers there.
